Christa Pawlowski

Dr. Pawlowski has over a decade of experience in the discovery and development of novel therapeutics in multiple therapeutic indications including cardiopulmonary diseases, hematology, and immuno-oncology. Prior to joining Allinaire, Dr. Pawlowski co-founded Haima Therapeutics, LLC, a biotechnology company focused on the development of a novel artificial platelet therapy for the treatment of bleeding and blood-related ailments. Dr. Pawlowski received her PhD in Biomedical Engineering from Case Western Reserve University in Cleveland, OH.